Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 540222 | NSE Symbol : LAURUSLABS | ISIN : INE947Q01028 | Industry : Pharmaceuticals |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
06-Jan-2025	24-Jan-2025	Quarterly Results	Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2025 inter alia to consider and approve the un-audited Financial Results of the Company for the quarter and nine months ended December 31 2024. Please see annexed enclosure. (As Per BSE Announcement Dated on: 24/01/2025)
17-Oct-2024	24-Oct-2024	Quarterly Results	Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/10/2024 inter alia to consider and approve We hereby inform you that a meeting of the Board of Directors of the Company will be held on Thursday October 24 2024 inter-alia: a) to consider and approve the Un-audited Financial Results of the Company for the quarter and half year ended September 30 2024; b) to consider the proposal for payment of Interim Dividend for FY 2024-25 and fixation of record date for determining the eligibility of shareholders if approved. Results - Half Year Ended September 30, 2024 Interim Dividend FY 2024-25 (As Per BSE Announcement Dated on: 24/10/2024)
19-Jul-2024	25-Jul-2024	Quarterly Results	Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2024 inter alia to consider and approve We hereby inform you that a meeting of the Board of Directors of the Company will be held on Thursday July 25 2024 inter-alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30 2024. Please see annexed enclosure (As per BSE Announcement Dated on 25/07/2024)
18-Apr-2024	25-Apr-2024	Quarterly Results	Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/04/2024 inter alia to consider and approve Audited Financial Results for FY 24 and Declaration of 2nd interim Dividend OUTCOME Changes in Directorate of the Company Q4 Financials interim dividend (As per BSE Announcement Dated on 25/04/2024)
17-Jan-2024	24-Jan-2024	Quarterly Results	Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2024 ,inter alia, to consider and approve unaudited financial results for the quarter and nine months ended December 31, 2023 Financial results for Q3 FY 2024 (As Per BSE Announcement dated on 24.01.2024)
13-Oct-2023	20-Oct-2023	Quarterly Results	Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/10/2023 inter alia to consider and approve 1) the Un-Audited Financial Results of the Company for the quarter and half year ended September 30 2023 2) the proposal for payment of Interim Dividend for FY 2023-24 3) other matters Interim Dividend FY 24 Q2 FY 24 Results Outcome of the Board Meeting dated October 20, 2023 (As per BSE Announcement Dated on 20/10/2023)
11-Sep-2023	11-Sep-2023	Acquisitions	Outcome of the Board Meeting dated September 11, 2023
20-Jul-2023	27-Jul-2023	Quarterly Results	Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2023 inter alia to consider and approve unaudited financial results for the quarter ended June 30 2023 LAURUS LABS LIMITED has informed BSE about Board Meeting to be held on 27 Jul 2023 to consider financial statements for the period ended June 2023. Financial results.
19-Apr-2023	27-Apr-2023	Accounts	Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/04/2023 inter alia to consider and approve Audited Financial Results and proposal for payment of 2nd Interim Dividend for FY 2022-23 The Board of Directors of the Company in their meeting held on April 27, 2023 have approved for the payment of 02nd interim dividend of Rs. 1.20/- (60%) per equity share of Rs.2/- each, for the Financial Year 2022-23. Further, pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, the Company has fixed 'May 10, 2023' as 'Record Date' for determining the eligibility of the Shareholders. The Dividend amount will be paid on or after May 18, 2023. The Board Meeting commenced at 02.00 PM and concluded at 02.45 PM. Financial Results for Q4 FY 2023 Outcome of the Board Meeting held on April 27, 2023 (As Per BSE Announcement Dated on 27.04.2023)
21-Jan-2023	30-Jan-2023	Quarterly Results	Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/01/2023 inter alia to consider and approve Un-Audited Financial Results of the Company for the quarter and nine months ended December 31 2022 Un-Audited Financial Results for Q3 FY 23 Outcome of Board Meeting held on January 30, 2023 (As Per BSE Announcement Dated on 30.01.2023)
13-Oct-2022	21-Oct-2022	Quarterly Results	Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/10/2022 inter alia to consider and approve Laurus Labs Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/10/2022inter alia to consider and approve Q2 FY 2022-23 Results and Interim Dividend for FY 23 Board approved:- 1. Approved the payment of interim dividend of Rs. 0.80 (40%) per equity share of Rs.2/- each, for the Financial Year 2022-23. 2. Approved for incorporation of new wholly owned subsidiary of the Company for Specialty Chemicals Business. (As Per BSE Bulletin Dated on 21.10.2022) Outcome of the Board Meeting held on October 21, 2022 Financial Results for Q2 FY 2022-23 The Board approved the dividend at the meeting held on October 21, 2022 (As per BSE Announcement Dated on 21/10/2022)
19-Jul-2022	27-Jul-2022	Quarterly Results	Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/07/2022 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company will be held on Wednesday July 27 2022 inter-alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended June 30 2022. Approval of un-audited Financial results for the Quarter ended June 30, 2022 (As Per BSE Announcement Dated on 27.07.2022)
21-Apr-2022	28-Apr-2022	Interim Dividend	Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/04/2022 inter alia to consider and approve Pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company will be held on Thursday April 28 2022 inter-alia: -.. to consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31 2022; -. to consider the proposal for payment of 2nd Interim Dividend for FY 2021-22 and fixation of record date for determining the eligibility of shareholders (if approved). Further the Companys trading window for dealing in securities by the Directors and Designated Persons has been closed from Friday April 01 2022 which was already intimated on March 30 2022 and shall continue to remain closed till Saturday April 30 2022 (both days inclusive). This is for your information and records. The Board of Directors of the Company in their meeting held on April 28, 2022 have approved for the payment of 02nd interim dividend of Rs. 1.20/- (60°/o) per equity share of Rs.2/- each, for the Financial Year 2021-22. Further, pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, the Company has fixed 'May 11, 2022' as 'Record Date' for determining the eligibility of the Shareholders. The Dividend amount will be paid on or after May 18, 2022. Approval of audited Financial Results for the Year ended March 31, 2022 and Limited Reviewed Financial Results for the Quarter ended March 31, 2022 Outcome of the Board Meeting - 28.04.2022 (As Per BSE Announcement Dated on 28.04.2022)
19-Jan-2022	27-Jan-2022	Quarterly Results	Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/01/2022 inter alia to consider and approve the Un-Audited Financial Results of the Company for the quarter and nine months ended December 31 2021 Q3 Financial Results for FY 2022 (As per BSE Announcement Dated on 27/01/2022)
20-Oct-2021	28-Oct-2021	Quarterly Results	Quarterly Results & Interim Dividend Laurus Labs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2021 ,inter alia, to consider and approve 1. to consider and approve the Un-Audited Financial Results of the Company for the quarter and half year ended September 30, 2021; 2. to consider the proposal for payment of Interim Dividend for FY 2021-22 and fixation of record date for determining the eligibility of shareholders (if approved). Board approved: Approved for the payment of interim dividend of Rs. 0.80/- ( 40°/o) per equity share of Rs.2/- each, for the Financial Year 2021-22. Further, pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, the Company has fixed 'November 18, 2021' as 'Record Date' for determining the eligibility of the Shareholders. The Dividend amount will be paid on or after November 25, 2021. (As Per BSE Bulletin Dated on 28.10.2021)

1 2

LOGIN HERE

Laurus Labs Ltd

Board Meeting